$162.78▼-3.06 (-1.84%)
Pre-Market:$162.91+0.13 (+0.08%)· 6:31 AM ET
Neurocrine Biosciences, Inc. (NBIX)
Operating Cash Flow
$1.07B
TTM · Period ending: · USD

NBIX Operating Cash Flow
Latest reported$1.07Bperiod ending
Latest reported$1.07Bperiod ending
NBIX Operating Cash Flow ($6.70M → $1.07B)
Annual operating cash flow
High-resolution chart · PNG
What is operating cash flow?
Cash generated from core business operations.
Compare operating cash flow
NBIX operating cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 782,700,000 | |
| 595,400,000 | |
| 389,900,000 | |
| 339,400,000 | |
| 256,500,000 | |
| 228,500,000 | |
| 147,000,000 | |
| 101,400,000 | |
| -94,331,000 | |
| -106,181,000 | |
| -37,997,000 | |
| -47,140,000 | |
| -29,607,000 | |
| -35,294,000 | |
| -698,000 | |
| 49,943,000 | |
| -53,095,000 | |
| -74,165,000 | |
| -59,334,000 | |
| -99,334,000 | |
| -30,794,000 | |
| -99,988,000 | |
| 37,128,000 | |
| -79,365,000 | |
| -21,856,000 | |
| -18,645,000 | |
| -10,300,000 | |
| -10,700,000 | |
| 11,000,000 | |
| 6,700,000 |
Explore More
NBIX Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance